根据收购方案,宜康医疗保健的所有股东可以选择以现金或现金加股份的方式接受收购。具体而言,股东可以选择每股0.330元的现金对价,或每股0.224元的现金对价加0.321148股Enabler Holdco普通股。收购对价较1月14日宜康医疗保健的闭市价0.275元,溢价约20%。 收购方案仍须获得股东和监管机构批准。如果方案成功实施,宜康医疗保健将从凯利板退市。 延伸阅读 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.